The long range goal of this project is to study structure-function relationships in cytochromes P-450 and related proteins using x-ray crystallography, molecular biology, and biochemistry. The only known P-450 crystal structure is that of P-450cam. In addition, the structure of several substrate and inhibitor complexes plus one mutant structure are known. This information will be used to guide the design, production, and structure determination of site-directed variants for the purpose of probing the mechanism of P-450 action and the design of novel P-450 catalysts. What is known from these previous studies also will be used to design inhibitors of P-450cam in order to develop a model for the rational design of useful P-450 therapeutic agents. These will be synthesized and the binding constants and crystal structures of the P-450cam-inhibitor complexes determined. Work also will continue on new P-450s and related proteins. In particular is the P-45OBM-3 enzyme which hydroxylates fatty acids. This P-450 contains both the heme domain and the FAD/FMN P450 reductase domain in a single polypeptide chain. Sequence comparisons also indicate that this bacterial P-450 is a good model for eukaryotic P-450s. The crystal structure of the entire protein and its domains will be determined. Other crystallographic projects include a P-450 which demethylates aromatic methoxy acids (P-450RR1) and the linalool hydroxylase (P-450lin). The common theme of all these projects is to better understand what structural features control substrate specificity and inter-protein electron transfer reactions in P-450s. Results from these studies should also have practical relevance in the design of P-450 inhibitors as useful therapeutic agents and the design of novel hydroxylases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM033688-10
Application #
2177088
Study Section
Biophysical Chemistry Study Section (BBCB)
Project Start
1987-03-01
Project End
1997-02-28
Budget Start
1994-03-01
Budget End
1995-02-28
Support Year
10
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Kaur, Parminder; Chamberlin, A Richard; Poulos, Thomas L et al. (2016) Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model. J Med Chem 59:4210-20
Poulos, Thomas L (2014) Heme enzyme structure and function. Chem Rev 114:3919-62
Sevrioukova, Irina F; Poulos, Thomas L (2014) Ritonavir analogues as a probe for deciphering the cytochrome P450 3A4 inhibitory mechanism. Curr Top Med Chem 14:1348-55
Madrona, Yarrow; Hollingsworth, Scott A; Tripathi, Sarvind et al. (2014) Crystal structure of cindoxin, the P450cin redox partner. Biochemistry 53:1435-46
Poulos, Thomas L; Madrona, Yarrow (2013) Oxygen activation and redox partner binding in cytochromes P450. Biotechnol Appl Biochem 60:128-33
Batabyal, Dipanwita; Poulos, Thomas L (2013) Crystal structures and functional characterization of wild-type CYP101D1 and its active site mutants. Biochemistry 52:8898-906
Sevrioukova, Irina F; Poulos, Thomas L (2013) Dissecting cytochrome P450 3A4-ligand interactions using ritonavir analogues. Biochemistry 52:4474-81
Sevrioukova, Irina F; Poulos, Thomas L (2013) Pyridine-substituted desoxyritonavir is a more potent inhibitor of cytochrome P450 3A4 than ritonavir. J Med Chem 56:3733-41
Madrona, Yarrow; Hollingsworth, Scott A; Khan, Bushra et al. (2013) P450cin active site water: implications for substrate binding and solvent accessibility. Biochemistry 52:5039-50
Sevrioukova, Irina F; Poulos, Thomas L (2013) Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems. Dalton Trans 42:3116-26

Showing the most recent 10 out of 68 publications